Ángeles Castro Iglesias-rekin lankidetzan egindako argitalpenak (23)

2019

  1. Predictors of hepatitis C treatment failure after using direct-acting antivirals in people living with human immunodeficiency virus

    Open Forum Infectious Diseases, Vol. 6, Núm. 3

2012

  1. Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial

    Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968

2011

  1. Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/Hepatitis C virus-coinfected patients treated for chronic hepatitis C

    Clinical Infectious Diseases, Vol. 53, Núm. 12, pp. 1291-1295

2005

  1. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2003

  1. Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

    AIDS, Vol. 17, Núm. 7, pp. 1023-1028

2002

  1. Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations

    Medical Science Monitor, Vol. 8, Núm. 9

1999

  1. Cd4+ T-lymphocytopenia, Kaposi's sarcoma, HHV-8 infection, severe seborrheic dermatitis, and onychomycosis in a homosexual man without HIV infection [4]

    International Journal of Dermatology

1997

  1. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 35, Núm. 3, pp. 225-230

  2. Co-infection with several HCV genotypes enhances liver damage in patients with chronic hepatitis C [3]

    Journal of Infection

  3. Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C [2]

    Journal of Infection

  4. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy [13]

    AIDS

1996

  1. Hepatitis C virus genotypes in different risk populations in Spain [4]

    Journal of Infectious Diseases

  2. Interferon α for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus

    Clinical Infectious Diseases, Vol. 23, Núm. 3, pp. 585-591

  3. Prevalencia de los genotipos del virus de la hepatitis C en drogadictos españoles con hepatitis crónica C

    Revista Clinica Espanola, Vol. 196, Núm. 10, pp. 673-677

  4. Propuesta de una escala de puntuación para decidir la opción terapéutica en la hepatitis crónica C en pacientes infectados por VIH

    Revista Clinica Espanola, Vol. 196, Núm. 7, pp. 488-491

  5. TRATAMIENTO DE LA HEPATITIS CRONICA C CON INTERFERON EN PACIENTES INFECTADOS POR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA

    Medicina Clinica, Vol. 106, Núm. 13, pp. 486-490

1995

  1. Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 31, Núm. 1, pp. 9-13

  2. High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain

    Journal of Hepatology, Vol. 22, Núm. 5, pp. 598-599

1994

  1. Absence of evidence of retroviral infection in idiopathic CD4+ T-lymphocytopenia syndrome [1]

    AIDS

  2. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C [1]

    AIDS